Delphi Private Advisors’s Ingevity NGVT Stock Holding History

Delphi Private Advisors’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4	Closed	–	–	235
2016 Q4	$0	Hold	4	–	–	﹤0.01%	387
2016 Q3	$0	Hold	4	–	–	﹤0.01%	521
2016 Q2	$0	Buy	+4	New	+$125	﹤0.01%	531

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

CIC

Chilton Investment Company Stamford, Connecticut $4.26B AUM 1.32% 1-Year Est. Return

Delphi Private Advisors's NGVT Position: Q1 2017 in Review

Delphi Private Advisors sold out of Ingevity (NGVT) in Q1 2017, closing a stake of 4 shares.

Delphi Private Advisors first reported a position in NGVT in Q2 2016 and held it in 3 quarters. The position peaked at $0 in Q4 2016. 250 funds tracked by Wall St. Rank hold NGVT as of Q1 2017.

Delphi Private Advisors reported no remaining Ingevity position as of Q1 2017 after selling out during the quarter.
Delphi Private Advisors sold 4 Ingevity shares in Q1 2017.
Delphi Private Advisors first reported a position in Ingevity in Q2 2016 and held it in 3 quarters.
Delphi Private Advisors's Ingevity position peaked at $0 in Q4 2016.
250 funds tracked by Wall St. Rank held Ingevity as of Q1 2017.

Based on Delphi Private Advisors's 13F filing for Q1 2017, filed 25 Apr 2017.